You are here
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
SBC: REPLIGEN CORPORATION Topic: N/A
ANGIOGENESIS IS A COMPLEX PROCESS INVOLVING THE PROLIFERATION, MIGRATION, AND PRECISE THREE DIMENSIONAL ALIGNMENT OF ENDOTHELIAL CELLS. A WIDE RANGE OF DISEASE PROCESSES INCLUDING SOLID TUMOR GROWTH, DIABETIC RETINOPATHY, INFLAMMATORY ARTHRITIS, AND PSORIASIS ARE ASSOCIATED WITH ABERRANT ANGIOGENESIS. IF RELATIVELY NON-TOXIC AGENTS WERE AVAILABLE TO INHIBIT ANGIOGENESIS SPECIFICALLY; MANAGEMENT OF ...SBIR Phase I 1991 Department of Health and Human Services
SBC: Cambridge Biotech Corp.ora- Ti Topic: N/A
THE LONG-TERM OBJECTIVE OF THIS PROJECT IS THE DEVELOPMENT OF AN EFFECTIVE VACCINE AGAINST HUMAN CYTOMEGALOVIRUS (CMV). TO ACCOMPLISH THIS, EXPERIMENTAL FORMULATIONS CONTAINING A UNIQUE AND SAFE PURIFIED SAPONIN ADJUVANT WILL BE COMPARED TO CONTROL PREPARATIONS IN SALINE, IN FREUND'S COMPLETE ADJUVANT, AND IN ALUMINUM HYDROXIDE. THE MODEL ANTIGENS WILL BE THE MAJOR CMV SURFACE GLYCOPROTEINS, GP55- ...SBIR Phase I 1991 Department of Health and Human Services